Last reviewed · How we verify
NCT05170607
Investigation of Specific Biomarkers in Patients With Atrial Fibrillation Who Undergo Interventional Treatment
trial testing Proteomic analysis by antibody microarrays in Atrial Fibrillation in 120 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | National Medical Research Center for Therapy and Preventive Medicine |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 January 2021 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Proteomic analysis by antibody microarrays
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
National Medical Research Center for Therapy and Preventive Medicine
Who can join
Adults 18 to 85, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The two main mechanisms for atrial fibrillation (AF) recurrence after cryoablation include Pulmonary vein (PV) reconnection and the presence of non-PV associated arrhythmic focuses. The aim of this study is to reveal the specific biomarkers by antibody microarrays.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Associations of adenovirus-reactive immunoglobulins with atrial fibrillation and body mass index.
Gumanova NG, Zlobina PD, Bogdanova NL, Brutyan HA, et al · · 2023 · cited 2× · PMID 37293276 · DOI 10.3389/fcvm.2023.1190051 -
Atrial fibrillation recurrence after catheter ablation is associated with RAD51 and p63 proteins.
Gumanova NG, Zlobina PD, Bogdanova NL, Brutyan HA, et al · · 2024 · cited 1× · PMID 38988509 · DOI 10.1016/j.heliyon.2024.e32874 -
Atrial Fibrillation Recurrence After Catheter Ablation Is Associated with TAG72 Protein.
Davtyan KV, Abdullaeva AA, Gumanova NG, Bogdanova NL, et al · · 2026 · PMID 41590866 · DOI 10.3390/jcdd13010039
Verify or expand the search:
- PubMed search for NCT05170607
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other National Medical Research Center for Therapy and Preventive Medicine trials
Trials by the same sponsor.
- NCT07375433 — Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course a · recruiting
- NCT07040800 — Adherence to Pharmacotherapy in Patients Admitted for Inpatient Treatment at the Scientific Medical Center (PRIMULA) · active not recruiting
- NCT06845384 — Registry of Acute Coronary Syndrome in the Regional Cardiovascular Center · active not recruiting
- NCT06803849 — Association of Heterogeneous Circulating Biomarkers and Anamnestic Factors of Pregnancy Adverse Course and Outcomes With · recruiting
- NCT06845397 — Chuvashia Inappropriate Prescribing Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05170607 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Medical Research Center for Therapy and Preventive Medicine
- Last refreshed: 14 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05170607.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing